Grifols Thrombin-A Prospective, Randomized, Double-Blind, Phase II Study to Evaluate the Safety and Efficacy of Topical Thrombin (Human) Grifols as an Adjunct to Hemostasis During Vascular, Parenchymous, Soft Tissue and Spinal Open Surgeries

Grants and Contracts Details

StatusFinished
Effective start/end date6/11/145/30/16

Funding

  • Grifols Biologicals Inc: $11,459.00